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Introduction 
In 2014 the number of death for from heart diseases in the United States was 614,348 and it represented 
the highest percentage (23.4%) of overall mortality [1]. The age-adjusted male/female cardiac-mortality 
ratio was 1.6 and it reflects the unbalanced pathophysiological responses between the two genders. The 
social effect of this disequilibrium is that Woman underrates their disease and further the entity of this 
issue. only 54% of women recognize that heart disease is their first cause of death, leading woman to 
delay treatment-seeking and to experience heart attacks more than men. Additionally, Framingham Risk 
Score frequently underestimates long-term risk in women [2] and recent evidences clearly shows that 
they are less likely to receive optimal timely reperfusion therapy than men [3]. Moreover, during the 
past years, the presence of the female gender has been generally underrepresented throughout the 
scientific literature and particularly in most of many clinical trials upon focusing on the ischemic heart 
disease (IHD). Inspired by a renewed awareness of this issue the matter, the researchers have been now 
reanalysing old data and developing conceiving focused prospective studies based on modern and 
thrilling technology such as computed tomography angiography (CTA) and cardiac magnetic resonance 
(CMR). In the light of the dramatic technological advances, CTA and CMR have been giving the 
possibility offer the ability to characterize both the coronary artery disease (CAD) and the myocardium 
to at a very high level of detail [4-6]. This could allow the imaging modality armamentarium to 
differentiate the pathophysiology of the IHD and other major heart diseases within each gender. Until 
now, few CTA and CMR studies addressed a direct comparisons between male and female populations 
[7-9]. In this paper We aim to review overview the non-invasive diagnostic role in a specific to gender’s 
dimension, mainly focusing on CTA and CMR in IHD, and to understand whether the existing evidences 
support a different diagnostic work-up approach.  
 
Anatomical gender differences at CMR and CTA 
Nowadays, CMR is regarded as the in vivo reference for quantitative assessment of the cardiac 
chambers, with CTA that has showed similar performance to CMR [10]. The Gender differences begins 
start with the anatomical and a physiological diversity of the cardiovascular system as reported [11]. 
Specifically, A cohort study of 804 strictly healthy Caucasian adults aged 45-74 has provided age- and 
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gender-specific CMR reference for the four cardiac chambers [12]. For instance, Both ventricular 
volumes have were reported to be larger in males compared to females both as absolute and indexed 
values.  
Beyond the differences in terms of cardiac chamber size, the second aspect that should be taken into 
consideration is related to the coronary arteries. Indeed, there is a reported increased morbidity and 
mortality in females associated with coronary revascularization. This discrepancy has been attributed to 
the fact that women have smaller coronary artery diameters than men, with the assumption that smaller 
coronary arteries may be correlated to smaller body habitus [12]. Studies based on invasive coronary 
angiography (ICA) cohorts may have collection bias as these patients are likely to be more symptomatic 
when compared to a more moderate risk cohort. On the other hand, noninvasive imaging by coronary 
CTA is more readily available and allows evaluation of the entire coronary tree without manipulation, ; 
therefore, it should be the reference standard for coronary diameter evaluation. Raggi et al. demonstrated 
that women have smaller coronary artery diameters in all vessels, and this difference is was not 
significantly related to weight, height, body surface index, body mass index, and left ventricle mass 
[13]. To recognize that women start with smaller luminal diameters, and are therefore prone to greater 
changes in luminal area from the same degree of atherosclerosis occurring in male counterparts, may 
support a more aggressive primary prevention strategy in females.   
 
Guidelines for CAD diagnosis in women: a need just partially explored 
The 2012 stable IHD guidelines from the American College of Cardiology/American Heart Association 
recommend using functional stress testing as the first-line diagnostic strategy and resorting to coronary 
CTA only if patients have a contraindication to stress testing or if they have a high likelihood of IHD 
and are unable to exercise [14]. Two years later, a consensus statement on the role of noninvasive testing 
in the clinical evaluation of women with suspected IHD was published. Echocardiography, myocardial 
perfusion imaging, or CMR are recommended for symptomatic women with abnormal rest ECG, 
functional disability, an indeterminate exercise treadmill testing (ETT) [15]. The role of coronary CTA 
was considered to be reasonable for women at intermediate IHD risk and, importantly, it was 
underscored the capability the ability of this technique to uniquely provide information on the burden 
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of CAD, which may be reasonable to guide posttest management strategies was undersored. On the 
contrary, and after a rigorous evidence based assessment but without taking into consideration specific 
gender differences, the latest version of UK NICE guidelines recommend coronary CTA as the first-line 
strategy limiting stress testing to be used only when CAD as seen on coronary CTA is of unknown 
significance or if the test is non diagnostic [16]. Even However, these guidelines may need to be further 
amended as we have learned more about fractional flow reserve derived from coronary CTA datasets 
(FFRCT) which has the potential to provide both anatomic and functional data about coronary stenosis. 
Such a diagnostic tool might be particularly useful in women, who are more likely than men to 
experience symptoms from non-obstructive CAD [17].  
 
Functional and anatomical approach for evaluation of chest pain suspected for from CAD: sex-
related differences 
From the analysis of throughout the literature it is possible to extrapolate some important features of 
CAD in woman women as compared with men man. The former more often has have atypical symptoms, 
presents a lower performance during exercise testing due to comorbidities, and shows a higher burden 
of coronary microvascular dysfunction.  
In the past 2 few years, a tremendous amount of much-needed data has been generated on the 
effectiveness of anatomic imaging by coronary CTA versus functional stress testing for stable patients 
with symptoms suspicious for CAD. Through the recent PROMISE (Prospective Multicenter Imaging 
Study for Evaluation of Chest Pain) trial [18], SCOT-HEART (Scottish Computed Tomography of the 
Heart) trial [19], and CRESCENT (Calcium Imaging and Selective CT Angiography in Comparison to 
Functional Testing for Suspected Coronary Artery Disease) trial [20], an impressively consistent picture 
of clinical outcome equivalence, if not superiority, equivalent if not superior clinical outcome has 
emerged between anatomic and stress testing favoring anatomic imaging using CT compared to stress 
testing. These trials demonstrate that coronary CTA is a safe, oftentimes superior and effective 
alternative to stress testing in the population of outpatients with stable chest pain. Yet, there has been 
hope that  Coronary CTA might be particularly beneficial in women who present with symptoms 
suspicious for myocardial ischemia. This group of patients deserves special attention because 
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overwhelming evidences documents that women experience higher false positive exercise stress testing 
tolerance test and nuclear stress tests compared with men [21] due, in particular, for instance secondary 
to a smaller heart size, breast attenuation, and a digitalis-like pattern induced by estrogen levels. This 
need is further reflected in the Indeed, women experience higher rates of adverse cardiovascular 
outcomes that women experience compared with their male counterparts and may, in part, explain the 
lower rate of obstructive CAD seen on angiography in women [22]. Particularly in women, with direct 
visualization of CAD, it is reasonable to hypothesize that coronary CTA would provide, particularly in 
women, greater diagnostic efficiency and clinical outcome efficacy than stress testing. Indeed, Benefit 
has already been shown in the more downstream patient population examined in ROMICAT-II (Rule 
Out Myocardial Infarction/Ischemia Using Computer Assisted Tomography II), which showed that 
women who present to the emergency department with acute chest pain have a greater reduction in 
length of stay with coronary CTA than men [8]. 
The PROMISE study showed that the most common presenting symptom among women was anginal 
chest pain, with men and women having similar rates of atypical chest pain, dispelling challenging the 
myth that women present with atypical symptoms more frequently than men [23]. Women had a higher 
burden of risk factors compared with men, including a higher prevalence of non-traditional risk factors 
not usually taken into account into with the traditional risk-estimation algorithms, such as depression, 
physical inactivity, and family history of premature CAD. Women were less likely than men to have a 
positive test (9.7% versus 15.1%; P <0.001), although diagnostic testing in the PROMISE trial was 
focused on the identification of obstructive CAD. In clinical practice, the full spectrum of IHD must be 
considered, given the adverse long-term prognosis associated with non-obstructive CAD in women who 
present with acute myocardial infarction (AMI) [24].  
The recent CRESCENT trial was a multicenter randomized controlled trial on coronary CTA versus 
functional stress testing in 350 stable chest pain patients in the Netherlands [20]. In a secondary analysis 
of this study, the authors found that compared with women in the stress-testing arm, women who 
underwent coronary CTA more frequently had chest pain resolution at 1 year (40% coronary CTA versus 
22% stress; P=0.026), although there was no difference in change in quality-of-life scores by testing 
arm. Furthermore, women in the coronary CTA arm more frequently reached a final diagnosis on the 
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same day of presentation compared with women in the stress-testing arm (86% coronary CTA versus 
44% stress; P<0.001), and this difference was greater than that seen in men (interaction P=0.011). Thus, 
the authors demonstrated substantial improvements in processes of care and diagnostic efficiency with 
coronary CTA testing in women.  
 
Left main coronary disease in women: insight from CONFIRM registry 
Obstructive left main, defined as ≥50% luminal stenosis, is associated with significant morbidity and 
mortality [25]. Importantly, non-obstructive CAD is frequently identified on ICA among patients with 
stable CAD and is more prevalent in symptomatic women (~60%) than in men (~30%). [17] 
Furthermore, recent investigations have described a strong association between non-obstructive CAD 
and adverse cardiovascular events in both invasive and noninvasive angiographic cohorts; however, 
comparative prognostic data of women versus men with non-obstructive CAD are limited. Recently, the 
study by Xie JX et al. [26] showed that non-obstructive left main plaque was associated with a nearly 
50% higher risk for adverse events among women independent of CAD burden in other vessels, whereas 
this association was not significant among men after risk adjustment. Moreover, women with non-
obstructive left main plaque had an ~1.8-fold higher risk for future events than men.  
Possible mechanisms for the association between non-obstructive left main plaque and adverse 
outcomes in women have been considered. Independently from body surface area, women are known to 
have significantly smaller coronary arterial sizes than men, including the luminal area of the left main, 
which has been associated with worse outcomes in women than men after coronary revascularization 
and may also increase susceptibility to thrombotic occlusion [27]. Numerous pathology examinations 
and intravascular ultrasound studies have also characterized differences in coronary atherosclerotic 
composition and progression between women and men. The higher prevalence of non-obstructive but 
positively remodeled plaques than men in women are suggested to be vulnerable lesions prone have 
been proposed to serve as precursor lesions vulnerable to future erosion or rupture [28].  
Microvascular dysfunction and non-obstructive CAD in Women 
Current evidence shows that women presenting signs and symptoms of myocardial ischemia in the 
absence of obstructive CAD do not have a good prognosis [29]. As compared with men of the same age, 
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young women with non-obstructive disease patterns have an unfavorable prognosis. In fact, the 
Women’s Ischemia Syndrome Evaluation (WISE) Study has shown that after 10 years of follow up, 
cardiovascular death or myocardial infarction occurred in 6.7% of women with no evidence of evident 
CAD, and in 12.8% of those with non-obstructive CAD. Furthermore, it is quite common for persistence 
of persistent chest pain or worsening of the symptoms over the years [30]. 
On the other hand, IHD in women may result from the interactions of many variables, such as focal 
stenosis, diffuse epicardial coronary narrowing, impaired endothelial shear stress and microvascular 
dysfunction, which make the diagnosis more difficult. In this context, it is well known that positron 
emission tomography (PET) can be useful thanks due to the ability to quantify myocardial blood flow 
(MBF) in absolute units and to calculate coronary flow reserve (CFR) [31,32]. More recently, it has 
been reported that excess cardiovascular risk in women was independently associated with severely 
impaired CFR (<1.6) in absence of obstructive CAD by ICA [33]. This finding is of clinical relevance 
because, as mentioned before, women have significantly lower burden of epicardial CAD as compared 
to men and absolute quantification of MBF may allow reclassifying their risk. In this context, coronary 
CTA can be performed in conjunction with myocardial perfusion PET imaging. This noninvasive 
approach allows integration of epicardial anatomy with the extent and characteristics of non-obstructive 
disease, which has been related to microvascular coronary flow [34]. The prognostic impact of non-
obstructive CAD has been demonstrated with coronary CTA, both using atherosclerotic burden indices 
indexes like the segment involvement score (SIS) and in combination with the tissue plaque 
characterization [35]. The employed indices indexes were able to highlight that patients with non-
obstructive CAD and high coronary atherosclerotic burden are at increased risk of coronary events.  The 
cause for coronary thrombus causing AMI and cardiac death seems to be sex related since erosion 
determines acute coronary thrombi in the majority of women 50 year-old who died suddenly. In parallel, 
coronary CTA has evolved to evaluate the hemodynamic significance of coronary lesions by several 
approaches, including stress myocardial perfusion, FFRCT, transluminal attenuation gradients, 
atherosclerotic plaque burden and characteristics, and more recently, CFR by means of dynamic CT 
perfusion acquisition techniques. In keeping with the relevant clinical meaning of non-obstructive CAD, 
this new technology, and in particular FFRCT has demonstrated been demonstrating that some coronary 
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plaque features, such as positive remodeling, are associated with myocardial ischemia independent of 
stenosis severity [36]. 
Therefore, the current multimodality imaging era allows us evaluate the whole spectrum of the 
atherosclerosis process and predict risk. Further studies are warranted to explore the complementary 
role of cardiac imaging techniques to identify women at risk.  
 
Pathophysiologic aspects of the Ischemic Heart Disease by CMR and their speculation in woman 
During the last years, CMR has been affirming its role as is a robust diagnostic tool in IHD thanks to 
with the high spatial and temporal resolutions determining elevated and the ability to characterize tissue 
of tissue characterization [37,38]. Particularly, The employment of gadolinium as a contrast agent allows 
us to image necrosis and inflammatory processes that are depicted as late gadolinium enhancement 
(LGE). zone, whereas In addiction, the increased myocardial signal intensity imaged by T2-weighted 
sequences represents the tissue edema in the first phases of myocardial infarction and active 
inflammation [39,40]. A bulk of Studies have demonstrated that the extent of scar tissue in infarcted 
myocardium portends poor prognosis. both high mass and percentage of scarred tissue in the context of 
infarcted myocardium have a strong negative prognostic meaning [41,42].  
From the past decade, CMR has been increasingly used for the evaluation of suspected myocardial 
ischemia in symptomatic women at intermediate-high IHD risk [43]. The analysis of perfusion using 
gadolinium contrast under vasodilator stress conditions, as such permitted by vasodilator agents, allows 
the distinction of for the discrimination between stress perfusion defect alone and stress perfusion defect 
plus abnormal wall motion, which has strong diagnostic and prognostic implications [44].  
Recently, MR-IMPACT II study compared perfusion-CMR and gated-SPECT for detection of CAD 
using ICA as the standard of reference in 123 women and 342 men enrolled from 33 centers in US and 
Europe [45]. Despite the analyzed population was significantly reduced by technical impediments, The 
study demonstrated equal equivalent diagnostic performance of CMR irrespective of gender, which was 
superior to SPECT (AUC in men, 0.75 vs 0.66, P=0.004; in women 0.76 versus 0.63; P=0.033). In the 
Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) trial, the 
gender-specific diagnostic performance of adenosine stress CMR and SPECT was compared in 235 
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women and 393 men with suspected angina. The sensitivity of CMR was significantly higher in both 
the female and male groups (88.7% vs 50.9% and 85.6% vs 70.8% respectively) and particularly in the 
former. Interestingly, the analysis of the only perfusion data revealed that CMR, not SPECT, showed 
similar diagnostic accuracy between the sex groups, and that the comparison between the two techniques 
demonstrated a superiority of CMR both in women and in men (area under the curve, 0.90 vs 0.67 and 
0.89 vs 0.74 respectively; P <0.0001) [46]. The multiparametric nature of CMR may contribute to 
explain the higher sensitivity, negative and positive predictive values in single-vessel and multi-vessel 
disease. Moreover, the high spatial resolution of CMR, as compared to SPECT, has an important role in 
overcoming the detrimental diagnostic factor represented by the smaller heart size in women. 
Differently from SPECT, CMR gives the possibility is able to delineate small subendocardial scars who 
may be subendocardial, as in IHD. or placed in multiple localization, as in other cardiac disease (e.g. 
myocarditis, dyspasia etc.).  Thanks to these singular properties, Importantly, CMR has been also 
employed is able to objectify myocardial damage caused by MI in the setting of no angiographically 
demonstrable evidence of obstructive CAD. In this scenario, women are represented more often than 
men.  
On the other hand, One of the limitation of ICA in this context consists is in the ability to resolve diffuse 
atherosclerosis of the coronary tree and to identify functional abnormalities of the whole coronary 
vasculature including the microcirculation. As discussed previously in the review article, one out of five 
Many patients with angina have normal coronary angiograms and, at the same time, objective signs of 
ischemia, such as downsloping ST-segment depressions at treadmill testing or a reversible defect 
detected by SPECT. In this clinical scenario, there have been conflicting data concerning the possible 
role of myocardial ischemia and, consequently, the results of the diagnostic imaging studies including 
those employing CMR are not unanimous. In the an attempt to explain the potential reasons for the 
ischemic findings of stress CMR in these patients, Pilz et al. [47] found that subendocardial stress 
perfusion deficits correlateds with slowed coronary artery flow in the absence of epicardial stenoses 
and, thus, suggesting microvascular disease as the cause of angina. Important insights on stress CMR 
specifically in women with symptoms of ischemia and no obstructive CAD were reported given by a 
study from the Women's Ischemia Syndrome Evaluation (WISE) [43]. Here, the authors found that 
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myocardial perfusion reserve index obtained by vasodilator stress first-pass perfusion CMR imaging 
was able to detect the coronary microvascular disease as defined by invasive coronary reactivity testing. 
Indeed, 118 symptomatic women had lower mean perfusion values compared to reference subjects (1.71 
vs 2.23, p<0.0001) whit a predictive capability of variables at invasive test.  
Another important question CMR is expected to give an able to answer to is whether coronary 
microvascular dysfunction is linked or even causes myocardial tissue damage. CMR is a well-validated 
method able to assess both expansion of the extracellular volume (ECV) and diffuse myocardial fibrosis 
employing T1 mapping techniques. One of the first attempts to study this possible association was 
performed in 14 symptomatic women enrolled in the WISE with proven myocardial ischemia and no 
obstructive CAD [48]. The authors found that native T1 values in women were significantly elevated 
compared with normal values (1039.8ms ± 35.1 vs 964.6 ± 35.3, p < 0.01) suggesting the presence of 
diffuse fibrosis in this subset of patients. A However, a subsequent report, the iPOWER study [49], did 
not confirm the same findings and, as consequence, it is evident that Further studies are warranted to 
elucidate  shed light to this matter.  
 
Final Considerations 
Reduction in cardiovascular deaths has have been dramatic for men but is significantly less evident in 
women. IHD affects women differently from men, starting from initial symptoms to clinical 
manifestations. Indeed, symptomatic women experience relatively worse outcomes compared with men. 
In clinical practice, the full spectrum of IHD is clinically relevant in women and must be considered 
with enhanced emphasis as compared to male counterparts. In particular, the framework of non-
obstructive CAD which subtend AMI occurrence is associated to with worse adverse long-term 
prognosis in females. To date, albeit evidences have failed to has not definitively identified gender-
specific imaging targets correlated to IHD risk, coronary CTA and CMR have been showing diagnostic 
and prognostic elements of conspicuous interest mostly in to women. For instance, non-obstructive left 
main disease is associated with a nearly 50% higher risk for adverse events among women independent 
of CAD burden in other vessels and an ~1.8-fold higher risk for future events than men. In the light of 
emerging highly performant novel CT technologies, such as FFRCT and CTP, it is expected in the next 
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future the accent on gender-specific aspects of atherosclerotic plaque strictly related to perfusion, MBF, 
and new pathophysiologic phenomena such as inflammation-related ischemia and shear stress will be 
elucidated. On the other hand, myocardial perfusion reserve index obtained by vasodilator stress first-
pass perfusion CMR imaging was is able to detect the coronary microvascular disease. However, further 
studies are needed to establish whether stress CMR detection of limited M CFR attributable to 
microvascular disease coronary in women with suspected myocardial ischemia and non-obstructive 
CAD improves IHD risk assessment. 
In conclusion, despite significant advancements in non-invasive cardiac imaging the renovated critical 
sense in the light of recent data, more evidences are is needed to support a gender-based first-line 
diagnostic work-up in IHD using state-of-the-art imaging strategies. Once that, it is likely that Integrated 
anatomic and physiological imaging techniques that identify diagnostic targets in each sex parameters 
specific to gender may lead to specific tailored treatment approaches with the ultimate goal of improving 
outcomes for patients.  
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